Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy

References

• CarmelietPAngiogenesis in health and diseaseNat Med20039665366012778163
   PubMed Web of Science ®Google Scholar
• FerraraNKerbelRSAngiogenesis as a therapeutic targetNature2005438707096797416355214
   PubMed Web of Science ®Google Scholar
• CarmelietPJainRKMolecular mechanisms and clinical applications of angiogenesisNature2011473734729830721593862
   PubMed Web of Science ®Google Scholar
• FerraraNGerberH-PLecouterJThe biology of VEGF and its receptorsNat Med20039666967612778165
   PubMed Web of Science ®Google Scholar
• KlettnerARoiderJComparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathwaysInvest Ophthalmol Vis Sci200849104523452718441313
   PubMed Web of Science ®Google Scholar
• FerraraNHillanKJGerberHPNovotnyWDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNat Rev Drug Discov20043539140015136787
   PubMed Web of Science ®Google Scholar
• WangYFeiDVanderlaanMSongABiological activity of bevacizumab, a humanized anti-VEGF antibody in vitroAngiogenesis20047433534515886877
   PubMedGoogle Scholar
• MailliezABaldiniCVanJTServentVMalletYBonneterreJNasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patientsBr J Cancer2010103677277520736943
   PubMed Web of Science ®Google Scholar
• NordenADYoungGSSetayeshKBevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrenceNeurology2008701077978718316689
   PubMed Web of Science ®Google Scholar
• RodriguesEBFarahMEMaiaMTherapeutic monoclonal antibodies in ophthalmologyProg Retin Eye Res200928211714419114125
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• SlowingIITrewynBGGiriSLinVSYMesoporous silica nanoparticles for drug delivery and biosensing applicationsAdv Funct Mater200717812251236
   Web of Science ®Google Scholar
• TangFLiLChenDMesoporous silica nanoparticles: synthesis, bio-compatibility and drug deliveryAdv Mater201224121504153422378538
   PubMed Web of Science ®Google Scholar
• GarianoRFGardnerTWRetinal angiogenesis in development and diseaseNature2005438707096096616355161
   PubMed Web of Science ®Google Scholar
• PieramiciDJRabenaMDAnti-VEGF therapy: comparison of current and future agentsEye200822101330133618497829
   PubMed Web of Science ®Google Scholar
• LynchSSChengCMBevacizumab for neovascular ocular diseasesAnn Pharmacother200741461462517355998
   PubMedGoogle Scholar
• AndreoliCMMillerJWAnti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurr Opin Ophthalmol200718650250818163003
   PubMed Web of Science ®Google Scholar
• ShenDYangJLiXBiphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheresNano Lett201414292393224467566
   PubMed Web of Science ®Google Scholar
• DaiZYuXHongJLiuXSunJSunXDevelopment of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosisMater Sci Eng C Mater Biol Appl20166620621427207056
   PubMedGoogle Scholar
• CruzLJTackenPJFokkinkRFigdorCGThe influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsBiomaterials201132286791680321724247
   PubMed Web of Science ®Google Scholar
• SimonsMGordonEClaesson-WelshLMechanisms and regulation of endothelial VEGF receptor signallingNat Rev Mol Cell Bio2016171061162527461391
   PubMed Web of Science ®Google Scholar
• RoshandelDEslaniMBaradaran-RafiiACurrent and upcoming therapies for corneal neovascularizationOcul Surf2018226761767
   Google Scholar
• ChenJSmithLEHRetinopathy of prematurityAngiogenesis200710213314017332988
   PubMedGoogle Scholar
• Vallet-RegíMOrdered mesoporous materials in the context of drug delivery systems and bone tissue engineeringChemistry200612235934594316832799
   PubMed Web of Science ®Google Scholar
• DoadrioJCSousaEMBIzquierdo-BarbaIDoadrioALPerez-ParienteJVallet-RegíMFunctionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery patternJ Mater Chem2006165462466
   Web of Science ®Google Scholar
• BalasFManzanoMHorcajadaPVallet-RegíMConfinement and controlled release of bisphosphonates on ordered mesoporous silica-based materialsJ Am Chem Soc2006128258116811716787058
   PubMed Web of Science ®Google Scholar
• TakahashiHLiBSasakiTMiyazakiCKajinoTInagakiSCatalytic activity in organic solvents and stability of immobilized enzymes depend on the pore size and surface characteristics of mesoporous silicaChem Mater2000121133013305
   Web of Science ®Google Scholar
• WengYLiuJJinSGuoWLiangXHuZNanotechnology-based strategies for treatment of ocular diseaseActa Pharm Sin B20177328129128540165
   PubMed Web of Science ®Google Scholar
• LiuCYaoMDLiCPSilencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunctionTheranostics20177112863287728824721
   PubMed Web of Science ®Google Scholar
• ChangJHGabisonEEKatoTAzarDTCorneal neovascularizationCurr Opin Ophthalmol200112424224911507336
   PubMed Web of Science ®Google Scholar
• GuptaDIllingworthCTreatments for corneal neovascularization: a reviewCornea201130892793821389854
   PubMed Web of Science ®Google Scholar
• KimSWHaBJKimEKTchahHKimTIThe effect of topical bevacizumab on corneal neovascularizationOphthalmology20081156e33e3818439681
   PubMedGoogle Scholar
• ParkKNanotechnology: what it can do for drug deliveryJ Control Release20071201–21317532520
   PubMedGoogle Scholar
• BhattaRSChandasanaHChhonkerYSMucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studiesInt J Pharm20124321–210511222569234
   PubMedGoogle Scholar
• MohammadpourMJabbarvandMHashemiHDelrishEProphylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burnAdv Biomed Res2015412426261826
   PubMedGoogle Scholar
• ConnorKMKrahNMDennisonRJQuantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesisNat Protoc20094111565157319816419
   PubMed Web of Science ®Google Scholar